Aragen Life Sciences expands its operations from Hyderabad
January 17, 2024
Cementing Hyderabad’s position as the epicentre of drug discovery and development services in Asia, Aragen Life Sciences has announced their expansion plans for investment of around INR 2000 crores and employment creation of around 1500 people in its existing facility in Mallapur, Telangana. The expansion is primarily targeted towards drug discovery, development and manufacturing activities for global life sciences industry.
The announcement was made after Hon’ble Chief Minister Mr. Revanth Reddy meeting with Mr. Manni Kantipudi, whole time Director & CEO, Aragen Life Sciences. Mr. Jayesh Ranjan IAS, Principal Secretary, Industries and Commerce Dept. and Mr. Shakthi M Nagappan, CEO, Telangana Life Sciences were also present during the meeting.
The expansion of Aragen Life Sciences has further solidified Hyderabad’s status as a hub for CROs (Contract Research Organizations) in India. The city also serves more than 1000 innovators globally in their efforts to discover and develop new drugs and devices.
Aragen boasts of more 20 years of experience providing a range of contract research, development and manufacturing services across the drug development continuum, with a focus on early-stage discovery and development of new molecular entities (NMEs). Whether large pharma or biotech, an agrochemical or animal health company, Aragen provides global resources and proven capabilities at every stage of the biopharma lifecycle, in small and large molecules.
Hon’ble Chief Minister Mr. Revanth Reddy said that “I’m delighted that Aragen Life Sciences, a global leader in pharma has expanded their operations from Hyderabad. This is a testament to vibrant ecosystem, extraordinary infrastructure and rich talent pool of our state that drives innovation.”
Mr. Manni Kantipudi added that “We are excited about our 5-year expansion plans and have decided to invest an additional 2000 Cr in Hyderabad, Telangana. Hyderabad has emerged as the undisputed national headquarters for CROs and CDMOs like Aragen over the years. Hyderabad offers modern infrastructure, access to the best scientific talent in the country, a strong network of suppliers, and an ecosystem that allows for innovation in digital technologies. We continue to see this industry grow and flourish in Telangana. We want to thank the Govt of Telangana for their strong support and approval of our expansion plans and look forward to completing these expansions in the coming years”.
For more information on Aragen Life Sciences-visit https://www.aragen.com/